5-[5-amino-6-[6-(3,5-dimethoxyphenyl)-4-methyl-5-oxopyrazin-2-yl]pyrazin-2-yl]-N-ethylpyridine-2-carboxamide;5-[3-amino-6-[3-methyl-1-(1-methylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-[3-methyl-1-(2-morpholin-4-ylethyl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-[5-methyl-1-(2-morpholin-4-ylethyl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-(3-methyl-1-piperidin-4-ylpyrazol-4-yl)pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-(5-methyl-3-pyridinyl)pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one

C155H173N45O21 — CID 159960706

IUPAC5-[5-amino-6-[6-(3,5-dimethoxyphenyl)-4-methyl-5-oxopyrazin-2-yl]pyrazin-2-yl]-N-ethylpyridine-2-carboxamide;5-[3-amino-6-[3-methyl-1-(1-methylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-[3-methyl-1-(2-morpholin-4-ylethyl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-[5-methyl-1-(2-morpholin-4-ylethyl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-(3-methyl-1-piperidin-4-ylpyrazol-4-yl)pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-(5-methyl-3-pyridinyl)pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one
SMILESCCNC(=O)c1ccc(-c2cnc(N)c(-c3cn(C)c(=O)c(-c4cc(OC)cc(OC)c4)n3)n2)cn1.COc1cc(OC)cc(-c2nc(-c3nc(-c4cn(C5CCN(C)CC5)nc4C)cnc3N)cn(C)c2=O)c1.COc1cc(OC)cc(-c2nc(-c3nc(-c4cn(C5CCNCC5)nc4C)cnc3N)cn(C)c2=O)c1.COc1cc(OC)cc(-c2nc(-c3nc(-c4cn(CCN5CCOCC5)nc4C)cnc3N)cn(C)c2=O)c1.COc1cc(OC)cc(-c2nc(-c3nc(-c4cncc(C)c4)cnc3N)cn(C)c2=O)c1.COc1cc(OC)cc(-c2nc(-c3nc(-c4cnn(CCN5CCOCC5)c4C)cnc3N)cn(C)c2=O)c1
InChIInChI=1S/2C27H32N8O4.C27H32N8O3.C26H30N8O3.C25H25N7O4.C23H22N6O3/c1-17-21(15-35(32-17)6-5-34-7-9-39-10-8-34)22-14-29-26(28)25(30-22)23-16-33(2)27(36)24(31-23)18-11-19(37-3)13-20(12-18)38-4;1-17-21(14-30-35(17)6-5-34-7-9-39-10-8-34)22-15-29-26(28)25(31-22)23-16-33(2)27(36)24(32-23)18-11-19(37-3)13-20(12-18)38-4;1-16-21(14-35(32-16)18-6-8-33(2)9-7-18)22-13-29-26(28)25(30-22)23-15-34(3)27(36)24(31-23)17-10-19(37-4)12-20(11-17)38-5;1-15-20(13-34(32-15)17-5-7-28-8-6-17)21-12-29-25(27)24(30-21)22-14-33(2)26(35)23(31-22)16-9-18(36-3)11-19(10-16)37-4;1-5-27-24(33)18-7-6-14(11-28-18)19-12-29-23(26)22(30-19)20-13-32(2)25(34)21(31-20)15-8-16(35-3)10-17(9-15)36-4;1-13-5-15(10-25-9-13)18-11-26-22(24)21(27-18)19-12-29(2)23(30)20(28-19)14-6-16(31-3)8-17(7-14)32-4/h2*11-16H,5-10H2,1-4H3,(H2,28,29);10-15,18H,6-9H2,1-5H3,(H2,28,29);9-14,17,28H,5-8H2,1-4H3,(H2,27,29);6-13H,5H2,1-4H3,(H2,26,29)(H,27,33);5-12H,1-4H3,(H2,24,26)
InChIKeyODHCGNDSNKTMAK-UHFFFAOYSA-N
MW3002.38 g/mol
LogP14.75
Rot. Bonds40

About 5-[5-amino-6-[6-(3,5-dimethoxyphenyl)-4-methyl-5-oxopyrazin-2-yl]pyrazin-2-yl]-N-ethylpyridine-2-carboxamide;5-[3-amino-6-[3-methyl-1-(1-methylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-[3-methyl-1-(2-morpholin-4-ylethyl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-[5-methyl-1-(2-morpholin-4-ylethyl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-(3-methyl-1-piperidin-4-ylpyrazol-4-yl)pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-(5-methyl-3-pyridinyl)pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one

5-[5-amino-6-[6-(3,5-dimethoxyphenyl)-4-methyl-5-oxopyrazin-2-yl]pyrazin-2-yl]-N-ethylpyridine-2-carboxamide;5-[3-amino-6-[3-methyl-1-(1-methylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-[3-methyl-1-(2-morpholin-4-ylethyl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-[5-methyl-1-(2-morpholin-4-ylethyl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-(3-methyl-1-piperidin-4-ylpyrazol-4-yl)pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-(5-methyl-3-pyridinyl)pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one (PubChem CID 159960706) has the molecular formula C155H173N45O21 and a molecular weight of 3002.38 g/mol. Its IUPAC name is 5-[5-amino-6-[6-(3,5-dimethoxyphenyl)-4-methyl-5-oxopyrazin-2-yl]pyrazin-2-yl]-N-ethylpyridine-2-carboxamide;5-[3-amino-6-[3-methyl-1-(1-methylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-[3-methyl-1-(2-morpholin-4-ylethyl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-[5-methyl-1-(2-morpholin-4-ylethyl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-(3-methyl-1-piperidin-4-ylpyrazol-4-yl)pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-(5-methyl-3-pyridinyl)pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one.

Molecular Properties

Compound Name5-[5-amino-6-[6-(3,5-dimethoxyphenyl)-4-methyl-5-oxopyrazin-2-yl]pyrazin-2-yl]-N-ethylpyridine-2-carboxamide;5-[3-amino-6-[3-methyl-1-(1-methylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-[3-methyl-1-(2-morpholin-4-ylethyl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-[5-methyl-1-(2-morpholin-4-ylethyl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-(3-methyl-1-piperidin-4-ylpyrazol-4-yl)pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-(5-methyl-3-pyridinyl)pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one
PubChem CID159960706
Molecular FormulaC155H173N45O21
Molecular Weight3002.38 g/mol
Exact Mass3000.39
IUPAC Name5-[5-amino-6-[6-(3,5-dimethoxyphenyl)-4-methyl-5-oxopyrazin-2-yl]pyrazin-2-yl]-N-ethylpyridine-2-carboxamide;5-[3-amino-6-[3-methyl-1-(1-methylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-[3-methyl-1-(2-morpholin-4-ylethyl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-[5-methyl-1-(2-morpholin-4-ylethyl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-(3-methyl-1-piperidin-4-ylpyrazol-4-yl)pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-(5-methyl-3-pyridinyl)pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one
SMILESCCNC(=O)c1ccc(-c2cnc(N)c(-c3cn(C)c(=O)c(-c4cc(OC)cc(OC)c4)n3)n2)cn1.COc1cc(OC)cc(-c2nc(-c3nc(-c4cn(C5CCN(C)CC5)nc4C)cnc3N)cn(C)c2=O)c1.COc1cc(OC)cc(-c2nc(-c3nc(-c4cn(C5CCNCC5)nc4C)cnc3N)cn(C)c2=O)c1.COc1cc(OC)cc(-c2nc(-c3nc(-c4cn(CCN5CCOCC5)nc4C)cnc3N)cn(C)c2=O)c1.COc1cc(OC)cc(-c2nc(-c3nc(-c4cncc(C)c4)cnc3N)cn(C)c2=O)c1.COc1cc(OC)cc(-c2nc(-c3nc(-c4cnn(CCN5CCOCC5)c4C)cnc3N)cn(C)c2=O)c1
InChIInChI=1S/2C27H32N8O4.C27H32N8O3.C26H30N8O3.C25H25N7O4.C23H22N6O3/c1-17-21(15-35(32-17)6-5-34-7-9-39-10-8-34)22-14-29-26(28)25(30-22)23-16-33(2)27(36)24(31-23)18-11-19(37-3)13-20(12-18)38-4;1-17-21(14-30-35(17)6-5-34-7-9-39-10-8-34)22-15-29-26(28)25(31-22)23-16-33(2)27(36)24(32-23)18-11-19(37-3)13-20(12-18)38-4;1-16-21(14-35(32-16)18-6-8-33(2)9-7-18)22-13-29-26(28)25(30-22)23-15-34(3)27(36)24(31-23)17-10-19(37-4)12-20(11-17)38-5;1-15-20(13-34(32-15)17-5-7-28-8-6-17)21-12-29-25(27)24(30-21)22-14-33(2)26(35)23(31-22)16-9-18(36-3)11-19(10-16)37-4;1-5-27-24(33)18-7-6-14(11-28-18)19-12-29-23(26)22(30-19)20-13-32(2)25(34)21(31-20)15-8-16(35-3)10-17(9-15)36-4;1-13-5-15(10-25-9-13)18-11-26-22(24)21(27-18)19-12-29(2)23(30)20(28-19)14-6-16(31-3)8-17(7-14)32-4/h2*11-16H,5-10H2,1-4H3,(H2,28,29);10-15,18H,6-9H2,1-5H3,(H2,28,29);9-14,17,28H,5-8H2,1-4H3,(H2,27,29);6-13H,5H2,1-4H3,(H2,26,29)(H,27,33);5-12H,1-4H3,(H2,24,26)
InChIKeyODHCGNDSNKTMAK-UHFFFAOYSA-N
XLogP14.75
TPSA797.27 Ų
H-Bond Donors8
H-Bond Acceptors65
Rotatable Bonds40
Heavy Atoms221
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003002.38
LogP ≤ 514.75
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1065

Analyze 5-[5-amino-6-[6-(3,5-dimethoxyphenyl)-4-methyl-5-oxopyrazin-2-yl]pyrazin-2-yl]-N-ethylpyridine-2-carboxamide;5-[3-amino-6-[3-methyl-1-(1-methylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-[3-methyl-1-(2-morpholin-4-ylethyl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-[5-methyl-1-(2-morpholin-4-ylethyl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-(3-methyl-1-piperidin-4-ylpyrazol-4-yl)pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-(5-methyl-3-pyridinyl)pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 5-[5-amino-6-[6-(3,5-dimethoxyphenyl)-4-methyl-5-oxopyrazin-2-yl]pyrazin-2-yl]-N-ethylpyridine-2-carboxamide;5-[3-amino-6-[3-methyl-1-(1-methylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-[3-methyl-1-(2-morpholin-4-ylethyl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-[5-methyl-1-(2-morpholin-4-ylethyl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-(3-methyl-1-piperidin-4-ylpyrazol-4-yl)pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-(5-methyl-3-pyridinyl)pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one?
The IUPAC name of 5-[5-amino-6-[6-(3,5-dimethoxyphenyl)-4-methyl-5-oxopyrazin-2-yl]pyrazin-2-yl]-N-ethylpyridine-2-carboxamide;5-[3-amino-6-[3-methyl-1-(1-methylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-[3-methyl-1-(2-morpholin-4-ylethyl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-[5-methyl-1-(2-morpholin-4-ylethyl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-(3-methyl-1-piperidin-4-ylpyrazol-4-yl)pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-(5-methyl-3-pyridinyl)pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one (CID 159960706) is 5-[5-amino-6-[6-(3,5-dimethoxyphenyl)-4-methyl-5-oxopyrazin-2-yl]pyrazin-2-yl]-N-ethylpyridine-2-carboxamide;5-[3-amino-6-[3-methyl-1-(1-methylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-[3-methyl-1-(2-morpholin-4-ylethyl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-[5-methyl-1-(2-morpholin-4-ylethyl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-(3-methyl-1-piperidin-4-ylpyrazol-4-yl)pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-(5-methyl-3-pyridinyl)pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one.
What is the SMILES notation for 5-[5-amino-6-[6-(3,5-dimethoxyphenyl)-4-methyl-5-oxopyrazin-2-yl]pyrazin-2-yl]-N-ethylpyridine-2-carboxamide;5-[3-amino-6-[3-methyl-1-(1-methylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-[3-methyl-1-(2-morpholin-4-ylethyl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-[5-methyl-1-(2-morpholin-4-ylethyl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-(3-methyl-1-piperidin-4-ylpyrazol-4-yl)pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-(5-methyl-3-pyridinyl)pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one?
The canonical SMILES for 5-[5-amino-6-[6-(3,5-dimethoxyphenyl)-4-methyl-5-oxopyrazin-2-yl]pyrazin-2-yl]-N-ethylpyridine-2-carboxamide;5-[3-amino-6-[3-methyl-1-(1-methylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-[3-methyl-1-(2-morpholin-4-ylethyl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-[5-methyl-1-(2-morpholin-4-ylethyl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-(3-methyl-1-piperidin-4-ylpyrazol-4-yl)pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-(5-methyl-3-pyridinyl)pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one is CCNC(=O)c1ccc(-c2cnc(N)c(-c3cn(C)c(=O)c(-c4cc(OC)cc(OC)c4)n3)n2)cn1.COc1cc(OC)cc(-c2nc(-c3nc(-c4cn(C5CCN(C)CC5)nc4C)cnc3N)cn(C)c2=O)c1.COc1cc(OC)cc(-c2nc(-c3nc(-c4cn(C5CCNCC5)nc4C)cnc3N)cn(C)c2=O)c1.COc1cc(OC)cc(-c2nc(-c3nc(-c4cn(CCN5CCOCC5)nc4C)cnc3N)cn(C)c2=O)c1.COc1cc(OC)cc(-c2nc(-c3nc(-c4cncc(C)c4)cnc3N)cn(C)c2=O)c1.COc1cc(OC)cc(-c2nc(-c3nc(-c4cnn(CCN5CCOCC5)c4C)cnc3N)cn(C)c2=O)c1.
What is the InChIKey of 5-[5-amino-6-[6-(3,5-dimethoxyphenyl)-4-methyl-5-oxopyrazin-2-yl]pyrazin-2-yl]-N-ethylpyridine-2-carboxamide;5-[3-amino-6-[3-methyl-1-(1-methylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-[3-methyl-1-(2-morpholin-4-ylethyl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-[5-methyl-1-(2-morpholin-4-ylethyl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-(3-methyl-1-piperidin-4-ylpyrazol-4-yl)pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-(5-methyl-3-pyridinyl)pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one?
The InChIKey is ODHCGNDSNKTMAK-UHFFFAOYSA-N. The full InChI is InChI=1S/2C27H32N8O4.C27H32N8O3.C26H30N8O3.C25H25N7O4.C23H22N6O3/c1-17-21(15-35(32-17)6-5-34-7-9-39-10-8-34)22-14-29-26(28)25(30-22)23-16-33(2)27(36)24(31-23)18-11-19(37-3)13-20(12-18)38-4;1-17-21(14-30-35(17)6-5-34-7-9-39-10-8-34)22-15-29-26(28)25(31-22)23-16-33(2)27(36)24(32-23)18-11-19(37-3)13-20(12-18)38-4;1-16-21(14-35(32-16)18-6-8-33(2)9-7-18)22-13-29-26(28)25(30-22)23-15-34(3)27(36)24(31-23)17-10-19(37-4)12-20(11-17)38-5;1-15-20(13-34(32-15)17-5-7-28-8-6-17)21-12-29-25(27)24(30-21)22-14-33(2)26(35)23(31-22)16-9-18(36-3)11-19(10-16)37-4;1-5-27-24(33)18-7-6-14(11-28-18)19-12-29-23(26)22(30-19)20-13-32(2)25(34)21(31-20)15-8-16(35-3)10-17(9-15)36-4;1-13-5-15(10-25-9-13)18-11-26-22(24)21(27-18)19-12-29(2)23(30)20(28-19)14-6-16(31-3)8-17(7-14)32-4/h2*11-16H,5-10H2,1-4H3,(H2,28,29);10-15,18H,6-9H2,1-5H3,(H2,28,29);9-14,17,28H,5-8H2,1-4H3,(H2,27,29);6-13H,5H2,1-4H3,(H2,26,29)(H,27,33);5-12H,1-4H3,(H2,24,26).
What are the key properties of 5-[5-amino-6-[6-(3,5-dimethoxyphenyl)-4-methyl-5-oxopyrazin-2-yl]pyrazin-2-yl]-N-ethylpyridine-2-carboxamide;5-[3-amino-6-[3-methyl-1-(1-methylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-[3-methyl-1-(2-morpholin-4-ylethyl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-[5-methyl-1-(2-morpholin-4-ylethyl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-(3-methyl-1-piperidin-4-ylpyrazol-4-yl)pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-(5-methyl-3-pyridinyl)pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one?
5-[5-amino-6-[6-(3,5-dimethoxyphenyl)-4-methyl-5-oxopyrazin-2-yl]pyrazin-2-yl]-N-ethylpyridine-2-carboxamide;5-[3-amino-6-[3-methyl-1-(1-methylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-[3-methyl-1-(2-morpholin-4-ylethyl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-[5-methyl-1-(2-morpholin-4-ylethyl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-(3-methyl-1-piperidin-4-ylpyrazol-4-yl)pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-(5-methyl-3-pyridinyl)pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one has a molecular weight of 3002.38 g/mol, XLogP of 14.75, 40 rotatable bonds, 8 hydrogen bond donors, and 65 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[5-amino-6-[6-(3,5-dimethoxyphenyl)-4-methyl-5-oxopyrazin-2-yl]pyrazin-2-yl]-N-ethylpyridine-2-carboxamide;5-[3-amino-6-[3-methyl-1-(1-methylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-[3-methyl-1-(2-morpholin-4-ylethyl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-[5-methyl-1-(2-morpholin-4-ylethyl)pyrazol-4-yl]pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-(3-methyl-1-piperidin-4-ylpyrazol-4-yl)pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one;5-[3-amino-6-(5-methyl-3-pyridinyl)pyrazin-2-yl]-3-(3,5-dimethoxyphenyl)-1-methylpyrazin-2-one is sourced from PubChem (CID 159960706), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).